Skip to main content
. 2022 Apr 21;12:874473. doi: 10.3389/fonc.2022.874473

Table 2.

Best tumor response according to the mRECIST.

Characteristics Combination Group (N = 56) No. (%) TACE Group (N = 54) No. (%) P value
CR 11 (19.6%) 2 (3.7%) 0.010
PR 27 (48.2%) 14 (25.9%)
SD 14 (25.0%) 29 (53.7%)
PD 4 (7.1%) 9 (16.7%)
ORR 38 (67.9%) 16 (29.6%) <0.001
DCR 52 (92.9%) 45 (83.3%) 0.122

Data are presented as n (%).

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, objective response rate; DCR, disease control rate; mRECIST, modified Response Evaluation Criteria In Solid Tumors.